V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001668 | 230006330 | 1.62 | 65.6 | null | 2020-03-29 | 2020-04-09 | Rucaparib | 02 | null | RUCAPARIB | 101809469 |
| 230001670 | 230006332 | 1.59 | 62.2 | null | null | 2019-12-24 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101591872 |
| 230001674 | 230006334 | null | null | null | 2019-01-03 | 2019-01-16 | null | N | null | CARBOPLATIN | 100741297 |
| 230001676 | 230006336 | null | null | null | 2018-04-12 | 2018-04-27 | Niraparib | 02 | null | NIRAPARIB | 101425965 |
| 230001677 | 230006337 | 1.6 | 62.5 | null | 2019-08-23 | 2019-08-29 | null | N | null | NIRAPARIB | 101013375 |
| 230001678 | 230006338 | 1.63 | 71.3 | Neo-adjuvant (N) | null | 2020-10-27 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101210411 |
| 230001684 | 230006342 | 1.68 | 72.3 | null | 2021-03-30 | 2021-04-13 | null | 02 | null | CISPLATIN + GEMCITABINE | 100078157 |
| 230001685 | 230006343 | 1.51 | 110.6 | Curative (C) | 2019-09-04 | 2019-09-08 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100397909 |
| 230001687 | 230006344 | 1.65 | 85.9 | null | 2021-05-22 | 2021-06-26 | null | null | null | CARBOPLATIN + GEMCITABINE | 101774313 |
| 230001688 | 230006345 | null | null | null | 2019-04-23 | 2020-01-04 | null | 02 | null | CISPLATIN | 100411615 |
| 230001689 | 230006346 | 1.57 | 63.85 | null | 2019-08-21 | 2020-02-14 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101682187 |
| 230001690 | 230006347 | null | null | null | null | 2019-04-20 | Olaparib | 02 | null | OLAPARIB | 100021121 |
| 230001691 | 230006348 | 1.62 | 89.5 | null | 2019-04-21 | 2019-08-09 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101268722 |
| 230001694 | 230006349 | 1.65 | 98.8 | Palliative (P) | 2019-08-04 | 2019-08-09 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101360279 |
| 230001697 | 230006351 | 1.58 | 70 | null | null | 2018-07-16 | IPILIMUMAB + NIVOLUMAB | N | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100546781 |
| 230001701 | 230006354 | 1.58 | 79.5 | null | null | 2018-07-02 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100154763 |
| 230001706 | 230006359 | 1.55 | 70.5 | Palliative (P) | 2015-05-11 | 2017-01-28 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100983724 |
| 230001710 | 230006360 | null | null | null | 2019-01-05 | 2019-01-05 | null | null | null | IPILIMUMAB + NIVOLUMAB | 101442407 |
| 230001713 | 230006362 | 1.53 | 61.9 | null | 2019-05-23 | 2019-06-08 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 100860635 |
| 230001715 | 230006363 | null | null | null | 2019-01-29 | 2019-02-14 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100533828 |
| 230001716 | 230006364 | 1.57 | 54.6 | null | null | 2020-04-26 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100797083 |
| 230001717 | 230006365 | 1.62 | 70.6 | null | null | 2019-04-14 | Bevacizumab+Carbo+Pacliaxel | 02 | null | TRIAL UNSPECIFIED | 101413067 |
| 230001720 | 230006367 | 1.68 | 93.8 | null | null | 2021-05-09 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100401581 |
| 230001721 | 230006368 | null | null | null | 2022-03-20 | 2022-03-31 | Olaparib | 02 | null | OLAPARIB | 100301518 |
| 230001723 | 230006369 | 1.52 | 59.8 | null | 2020-05-31 | 2021-01-23 | null | 02 | null | PEMBROLIZUMAB | 101704693 |
| 230001732 | 230006373 | 1.6 | 114 | null | null | 2017-02-15 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101640570 |
| 230001733 | 230006374 | 1.86 | 93.6 | null | null | 2018-12-04 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100913514 |
| 230001737 | 230006377 | null | null | Curative (C) | 2020-01-28 | 2020-01-28 | null | null | N | IPILIMUMAB + NIVOLUMAB | 101092550 |
| 230001739 | 230006378 | null | null | null | 2021-07-05 | 2021-07-22 | Olaparib | 02 | null | OLAPARIB | 100856639 |
| 230001747 | 230006384 | null | null | null | null | 2019-08-05 | Trastuzumab Subcutaneous | 02 | null | CISPLATIN + ETOPOSIDE | 100310453 |
| 230001751 | 230006386 | 1.54 | 127 | null | null | 2019-07-12 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101665032 |
| 230001753 | 230006387 | 1.67 | 60.8 | null | 2016-04-09 | 2016-04-24 | null | 01 | null | NIRAPARIB | 101149790 |
| 230001754 | 230006388 | null | null | null | 2019-11-26 | 2019-12-09 | null | null | null | BEVACIZUMAB | 101336225 |
| 230001756 | 230006390 | null | null | null | 2019-08-04 | 2019-08-10 | null | null | null | GEMCITABINE | 101584309 |
| 230001760 | 230006393 | 1.65 | 73.1 | null | 2017-09-10 | 2017-09-17 | null | Y | null | PACLITAXEL | 101027801 |
| 230001762 | 230006394 | null | null | Neo-adjuvant (N) | 2016-07-19 | 2016-07-23 | null | 02 | null | CAPECITABINE + OXALIPLATIN | 101493624 |
| 230001763 | 230006395 | 1.61 | 72 | null | 2016-12-15 | 2016-12-31 | Carboplatin + Docetaxel | 02 | null | ICON8B TRIAL | 100434937 |
| 230001764 | 230006396 | null | null | Palliative (P) | 2018-12-24 | 2018-12-24 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101340797 |
| 230001766 | 230006398 | 1.67 | 80.8 | Palliative (P) | 2018-04-16 | 2018-04-27 | null | null | N | HYDROXYCARBAMIDE | 100506918 |
| 230001770 | 230006401 | null | null | null | 2017-09-14 | 2019-12-11 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 100978318 |
| 230001774 | 230006403 | null | null | null | null | 2020-01-12 | Niraparib | 02 | null | NIRAPARIB | 101164593 |
| 230001775 | 230006404 | 1.67 | 72.8 | null | null | 2019-07-26 | Olaparib | 02 | null | OLAPARIB | 100888768 |
| 230001776 | 230006405 | 1.6 | 58.3 | null | 2019-02-19 | 2019-03-09 | Cisplatin 7 day | null | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101310876 |
| 230001777 | 230006406 | null | null | null | null | 2019-12-30 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 100192425 |
| 230001785 | 230006411 | 1.59 | 89 | null | null | 2019-11-26 | Niraparib | 02 | null | NIRAPARIB | 101288231 |
| 230001787 | 230006413 | 1.7 | 80 | Curative (C) | null | 2019-11-15 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101286448 |
| 230001790 | 230006415 | 1.6 | 100 | null | 2021-05-23 | 2021-06-04 | Rucaparib | 02 | null | RUCAPARIB | 101252158 |
| 230001791 | 230006416 | 1.7 | 57 | null | null | 2019-11-10 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101315938 |
| 230001793 | 230006417 | 1.7 | 51.5 | Palliative (P) | null | 2018-07-23 | Carboplatin + Docetaxel | 02 | N | TRIAL UNSPECIFIED | 101607821 |
| 230001796 | 230006419 | 1.5 | 47.5 | null | 2020-08-19 | 2021-11-28 | null | null | null | CARBOPLATIN + GEMCITABINE | 101239014 |